Human monocyte-derived macrophages inhibit HCMV spread independent of classical antiviral cytokines

References

• Griffiths P, Baraniak I, Reeves M. The pathogenesis of human cytomegalovirus. J Pathol. 2015;235:288–297.
   PubMed Web of Science ®Google Scholar
• Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15:680–715.
   PubMed Web of Science ®Google Scholar
• Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J Gen Virol. 2006;87:1763–1779.
   PubMed Web of Science ®Google Scholar
• Pawelec G. Immunosenenescence: role of cytomegalovirus. Exp Gerontol. 2014;54:1–5.
   PubMed Web of Science ®Google Scholar
• Loewendorf A, Benedict CA. Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J Intern Med. 2010;267:483–501.
   PubMed Web of Science ®Google Scholar
• Hengel H, Brune W, Koszinowski UH. Immune evasion by cytomegalovirus–survival strategies of a highly adapted opportunist. Trends Microbiol. 1998;6:190–197.
   PubMed Web of Science ®Google Scholar
• Rawlinson WD, Farrell HE, Barrell BG. Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol. 1996;70:8833–8849.
   PubMed Web of Science ®Google Scholar
• Emodi G, O’Reilly R, Muller A, et al. Effect of human exogenous leukocyte interferon in cytomegalovirus infections. J Infect Dis. 1976;133(Suppl):A199–204.
   PubMed Web of Science ®Google Scholar
• Wen Y, Liu P. Interferon successfully inhibited refractory cytomegalovirus infection and resulted in CD4+ T-cells increase in a patient with AIDS. HIV Clin Trials. 2011;12:118–120.
   PubMed Web of Science ®Google Scholar
• Presti RM, Pollock JL, Dal Canto AJ, et al. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med. 1998;188:577–588.
   PubMed Web of Science ®Google Scholar
• Gil MP, Bohn E, O’Guin AK, et al. Biologic consequences of Stat1-independent IFN signaling. Proc Natl Acad Sci U S A. 2001;98:6680–6685.
   PubMed Web of Science ®Google Scholar
• McNab F, Mayer-Barber K, Sher A, et al. Type I interferons in infectious disease. Nat Rev Immunol. 2015;15:87–103.
   PubMed Web of Science ®Google Scholar
• Crouse J, Kalinke U, Oxenius A. Regulation of antiviral T cell responses by type I interferons. Nat Rev Immunol. 2015;15:231–242.
   PubMed Web of Science ®Google Scholar
• Swiecki M, Colonna M. Type I interferons: diversity of sources, production pathways and effects on immune responses. Curr Opin Virol. 2011;1:463–475.
   PubMed Web of Science ®Google Scholar
• Paijo J, Doring M, Spanier J, et al. cGAS senses human cytomegalovirus and induces type I interferon responses in human monocyte-derived cells. PLoS Pathog. 2016;12:e1005546.
   PubMed Web of Science ®Google Scholar
• Paijo J, Kaever V, Kalinke U. cGAMP quantification in virus-infected human monocyte-derived cells by HPLC-coupled tandem mass spectrometry. Methods Mol Biol. 2017;1656:153–166.
   PubMedGoogle Scholar
• Sinzger C, Plachter B, Grefte A, et al. Tissue macrophages are infected by human cytomegalovirus in vivo. J Infect Dis. 1996;173:240–245.
   PubMed Web of Science ®Google Scholar
• Sinzger C, Digel M, Jahn G. Cytomegalovirus cell tropism. Curr Top Microbiol Immunol. 2008;325:63–83.
   PubMed Web of Science ®Google Scholar
• Sinzger C, Grefte A, Plachter B, et al. Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. J Gen Virol. 1995;76(Pt 4):741–750.
   PubMed Web of Science ®Google Scholar
• Sacher T, Mohr CA, Weyn A, et al. The role of cell types in cytomegalovirus infection in vivo. Eur J Cell Biol. 2012;91:70–77.
   PubMed Web of Science ®Google Scholar
• Sampaio KL, Cavignac Y, Stierhof YD, et al. Human cytomegalovirus labeled with green fluorescent protein for live analysis of intracellular particle movements. J Virol. 2005;79:2754–2767.
   PubMed Web of Science ®Google Scholar
• Sinzger C, Hahn G, Digel M, et al. Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. J Gen Virol. 2008;89:359–368.
   PubMed Web of Science ®Google Scholar
• Dreux M, Garaigorta U, Boyd B, et al. Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity. Cell Host Microbe. 2012;12:558–570.
   PubMed Web of Science ®Google Scholar
• Grabski E, Wappler I, Pfaender S, et al. Efficient virus assembly, but not infectivity, determines the magnitude of hepatitis C virus-induced interferon alpha responses of plasmacytoid dendritic cells. J Virol. 2015;89:3200–3208.
   PubMed Web of Science ®Google Scholar
• Bruni D, Chazal M, Sinigaglia L, et al. Viral entry route determines how human plasmacytoid dendritic cells produce type I interferons. Sci Signal. 2015;8:ra25.
   PubMed Web of Science ®Google Scholar
• Frenz T, Graalmann L, Detje CN, et al. Independent of plasmacytoid dendritic cell (pDC) infection, pDC triggered by virus-infected cells mount enhanced type I IFN responses of different composition as opposed to pDC stimulated with free virus. J Immunol. 2014;193:2496–2503.
   PubMed Web of Science ®Google Scholar
• Schneider K, Loewendorf A, De Trez C, et al. Lymphotoxin-mediated crosstalk between B cells and splenic stroma promotes the initial type I interferon response to cytomegalovirus. Cell Host Microbe. 2008;3:67–76.
   PubMed Web of Science ®Google Scholar
• Holzki JK, Dag F, Dekhtiarenko I, et al. Type I interferon released by myeloid dendritic cells reversibly impairs cytomegalovirus replication by inhibiting immediate early gene expression. J Virol. 2015;89:9886–9895.
   PubMed Web of Science ®Google Scholar
• Doring M, Lessin I, Frenz T, et al. M27 expressed by cytomegalovirus counteracts effective type I interferon induction of myeloid cells but not of plasmacytoid dendritic cells. J Virol. 2014;88:13638–13650.
   PubMed Web of Science ®Google Scholar
• Gredmark S, Tilburgs T, Soderberg-Naucler C. Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J Virol. 2004;78:10378–10389.
   PubMed Web of Science ®Google Scholar
• Romo N, Magri G, Muntasell A, et al. Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization. J Leukocyte Biol. 2011;90:717–726.
   PubMed Web of Science ®Google Scholar
• Kvale EO, Dalgaard J, Lund-Johansen F, et al. CD11c+ dendritic cells and plasmacytoid DCs are activated by human cytomegalovirus and retain efficient T cell-stimulatory capability upon infection. Blood. 2006;107:2022–2029.
   PubMed Web of Science ®Google Scholar
• Varani S, Cederarv M, Feld S, et al. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J Immunol. 2007;179:7767–7776.
   PubMed Web of Science ®Google Scholar
• Chang WL, Barry PA, Szubin R, et al. Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology. 2009;390:330–337.
   PubMed Web of Science ®Google Scholar
• Detrick B, Rhame J, Wang Y, et al. Cytomegalovirus replication in human retinal pigment epithelial cells. Altered expression of viral early proteins. Invest Ophthalmol Vis Sci. 1996;37:814–825.
   PubMed Web of Science ®Google Scholar
• Miceli MV, Newsome DA, Novak LC, et al. Cytomegalovirus replication in cultured human retinal pigment epithelial cells. Curr Eye Res. 1989;8:835–839.
   PubMed Web of Science ®Google Scholar
• Sampaio KL, Weyell A, Subramanian N, et al. A TB40/E-derived human cytomegalovirus genome with an intact US-gene region and a self-excisable BAC cassette for immunological research. BioTechniques. 2017;63:205–214.
   PubMed Web of Science ®Google Scholar
• Schroder K, Hertzog PJ, Ravasi T, et al. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75:163–189.
   PubMed Web of Science ®Google Scholar
• Davignon JL, Castanie P, Yorke JA, et al. Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro. J Virol. 1996;70:2162–2169.
   PubMed Web of Science ®Google Scholar
• Karupiah G, Xie QW, Buller RM, et al. Inhibition of viral replication by interferon-gamma-induced nitric oxide synthase. Science. 1993;261:1445–1448.
   PubMed Web of Science ®Google Scholar
• Ruby J, Bluethmann H, Peschon JJ. Antiviral activity of tumor necrosis factor (TNF) is mediated via p55 and p75 TNF receptors. J Exp Med. 1997;186:1591–1596.
   PubMed Web of Science ®Google Scholar
• Colamonici OR, Domanski P, Sweitzer SM, et al. Vaccinia virus B18R gene encodes a type I interferon-binding protein that blocks interferon alpha transmembrane signaling. J Biol Chem. 1995;270:15974–15978.
   PubMed Web of Science ®Google Scholar
• Symons JA, Alcami A, Smith GL. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell. 1995;81:551–560.
   PubMed Web of Science ®Google Scholar
• Alcami A, Symons JA, Smith GL. The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. J Virol. 2000;74:11230–11239.
   PubMed Web of Science ®Google Scholar
• Montanuy I, Alejo A, Alcami A. Glycosaminoglycans mediate retention of the poxvirus type I interferon binding protein at the cell surface to locally block interferon antiviral responses. FASEB J. 2011;25:1960–1971.
   PubMed Web of Science ®Google Scholar
• Ito T, Kanzler H, Duramad O, et al. Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells. Blood. 2006;107:2423–2431.
   PubMed Web of Science ®Google Scholar
• Barchet W, Cella M, Odermatt B, et al. Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo. J Exp Med. 2002;195:507–516.
   PubMed Web of Science ®Google Scholar
• Siegal FP, Kadowaki N, Shodell M, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284:1835–1837.
   PubMed Web of Science ®Google Scholar
• Delale T, Paquin A, Asselin-Paturel C, et al. MyD88-dependent and -independent murine cytomegalovirus sensing for IFN- release and initiation of immune responses in vivo. J Immunol. 2005;175:6723–6732.
   PubMed Web of Science ®Google Scholar
• Hokeness KL, Deweerd ES, Munks MW, et al. CXCR3-dependent recruitment of antigen-specific T lymphocytes to the liver during murine cytomegalovirus infection. J Virol. 2007;81:1241–1250.
   PubMed Web of Science ®Google Scholar
• Iversen MB, Reinert LS, Thomsen MK, et al. An innate antiviral pathway acting before interferons at epithelial surfaces. Nat Immunol. 2016;17:150–158.
   PubMed Web of Science ®Google Scholar
• Buttmann M, Berberich-Siebelt F, Serfling E, et al. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells. J Vasc Res. 2007;44:51–60.
   PubMed Web of Science ®Google Scholar
• Liu M, Guo S, Hibbert JM, et al. CXCL10/IP-10 in infectious diseases pathogenesis and potential therapeutic implications. Cytokine Growth Factor Rev. 2011;22:121–130.
   PubMed Web of Science ®Google Scholar
• Sinzger C, Mangin M, Weinstock C, et al. Effect of serum and CTL on focal growth of human cytomegalovirus. J Clin Virol. 2007;38:112–119.
   PubMed Web of Science ®Google Scholar
• Wu Z, Sinzger C, Reichel JJ, et al. Natural killer cells can inhibit the transmission of human cytomegalovirus in cell culture by using mechanisms from innate and adaptive immune responses. J Virol. 2015;89:2906–2917.
   PubMed Web of Science ®Google Scholar
• Jackson SE, Mason GM, Okecha G, et al. Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells. J Virol. 2014;88:10894–10908.
   PubMed Web of Science ®Google Scholar
• Iversen AC, Norris PS, Ware CF, et al. Human NK cells inhibit cytomegalovirus replication through a noncytolytic mechanism involving lymphotoxin-dependent induction of IFN-beta. J Immunol. 2005;175:7568–7574.
   PubMed Web of Science ®Google Scholar
• Kasmapour B, Kubsch T, Rand U, et al. Myeloid dendritic cells repress human cytomegalovirus gene expression and spread by releasing interferon-unrelated soluble antiviral factors. J Virol. 2018;92(1).
   Web of Science ®Google Scholar
• Murrell I, Bedford C, Ladell K, et al. The pentameric complex drives immunologically covert cell-cell transmission of wild-type human cytomegalovirus. Proc Natl Acad Sci U S A. 2017;114:6104–6109.
   PubMed Web of Science ®Google Scholar
• Sinzger C, Knapp J, Plachter B, et al. Quantification of replication of clinical cytomegalovirus isolates in cultured endothelial cells and fibroblasts by a focus expansion assay. J Virol Methods. 1997;63:103–112.
   PubMed Web of Science ®Google Scholar
• Riegler S, Hebart H, Einsele H, et al. Monocyte-derived dendritic cells are permissive to the complete replicative cycle of human cytomegalovirus. J Gen Virol. 2000;81:393–399.
   PubMed Web of Science ®Google Scholar
• Borst EM, Standker L, Wagner K, et al. A peptide inhibitor of cytomegalovirus infection from human hemofiltrate. Antimicrob Agents Chemother. 2013;57:4751–4760.
   PubMed Web of Science ®Google Scholar